With deliveries from Johnson & Johnson set to fall 86 percent, a White House official warned that the vaccine would be scarce until a troubled Baltimore plant gains regulatory approval. By Sharon LaFraniere, Noah Weiland and Jennifer Steinhauer from NYT U.S. https://ift.tt/323t2W6